Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the the safety, pharmacokinetics, radiation
dosimetry of HRS-9815 for PET/CT imaging in adult patients with prostate cancer.